| Preface |
|
xv | |
| Disclaimer |
|
xvii | |
|
Principles of Industry Immersion Learning |
|
|
1 | (16) |
|
|
|
|
|
2 | (1) |
|
Building a University --- Industry Alliance |
|
|
3 | (3) |
|
Educational Needs Assessment |
|
|
3 | (1) |
|
|
|
3 | (2) |
|
|
|
5 | (1) |
|
|
|
5 | (1) |
|
|
|
5 | (1) |
|
Design, Format, and Model Examples of Case Studies |
|
|
6 | (2) |
|
Example 1: Technology Development |
|
|
6 | (1) |
|
Example 2: Product Assessment |
|
|
7 | (1) |
|
Example 3: Business Development |
|
|
7 | (1) |
|
Basics of Industry Immersion Learning |
|
|
8 | (1) |
|
Definition and Characterization |
|
|
8 | (1) |
|
The Immersion Environment |
|
|
8 | (1) |
|
Sample Work Flow of an Immersion Case Study |
|
|
8 | (1) |
|
|
|
8 | (1) |
|
Predicted Learning Outcomes |
|
|
9 | (1) |
|
Assessment of Actual Learning Outcomes |
|
|
10 | (1) |
|
Overview of Selected Case Studies |
|
|
10 | (1) |
|
Logistics of Industry Immersion Teaching |
|
|
11 | (4) |
|
|
|
11 | (1) |
|
Instructor and Instructor Affiliation |
|
|
11 | (2) |
|
|
|
13 | (1) |
|
|
|
13 | (1) |
|
|
|
14 | (1) |
|
|
|
14 | (1) |
|
|
|
15 | (1) |
|
Publishing of Industry Immersion Case Studies |
|
|
15 | (2) |
|
Integration of Pharmaceutical and Diagnostic Co-Development and Commercialization: Adding Value to Therapeutics by Applying Biomarkers |
|
|
17 | (24) |
|
|
|
|
|
18 | (1) |
|
|
|
18 | (1) |
|
Predicted Learning Outcomes |
|
|
19 | (1) |
|
|
|
19 | (14) |
|
Current Environment for Pharmaceutical and Diagnostic Product Development |
|
|
21 | (4) |
|
Potential Solutions to the Challenges Confronting Pharma |
|
|
25 | (1) |
|
Genomics and Proteomics, Metabolomics, and ``Other -omics'' |
|
|
25 | (1) |
|
|
|
26 | (1) |
|
|
|
26 | (1) |
|
Drug Development for Targeted Cancer Therapies |
|
|
27 | (1) |
|
Tamoxifen in Estrogen-Receptor-Positive Breast Cancer |
|
|
27 | (1) |
|
Trastuzumab (Herceptin) in Breast Cancers Overexpressing Her2 |
|
|
28 | (1) |
|
Imatinib (Gleevec) in Chronic Myelogenous Leukemia and Gastrointestinal Stromal Tumors |
|
|
29 | (1) |
|
|
|
30 | (1) |
|
Specific Example of Lapatinib (Tykerb) |
|
|
30 | (1) |
|
Leveraging Biomarkers and Diagnostics to Accelerate Drug Development |
|
|
30 | (2) |
|
Potential to Enhance Commercial Success with Companion Diagnostics |
|
|
32 | (1) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
|
|
34 | (1) |
|
Study Plan and Assignments |
|
|
34 | (7) |
|
|
|
34 | (1) |
|
|
|
35 | (1) |
|
|
|
35 | (1) |
|
|
|
36 | (3) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (2) |
|
Product Portfolio Planning and Management in the Pharmaceutical Industry |
|
|
41 | (20) |
|
|
|
|
|
42 | (1) |
|
|
|
42 | (1) |
|
Predicted Learning Outcomes |
|
|
43 | (1) |
|
|
|
43 | (3) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (2) |
|
|
|
46 | (1) |
|
|
|
47 | (1) |
|
Study Plan and Assignments |
|
|
47 | (14) |
|
|
|
47 | (2) |
|
|
|
49 | (2) |
|
|
|
51 | (1) |
|
|
|
52 | (3) |
|
|
|
55 | (1) |
|
|
|
55 | (1) |
|
|
|
55 | (1) |
|
|
|
55 | (3) |
|
Appendix A: Method for Net Present Value Calculations |
|
|
58 | (1) |
|
Appendix B: Glossary of Abbreviations and Terms |
|
|
59 | (2) |
|
Entrepreneurship: Establishing a New Biotechnology Venture |
|
|
61 | (18) |
|
|
|
|
|
62 | (1) |
|
|
|
62 | (1) |
|
Predicted Learning Outcomes |
|
|
62 | (1) |
|
|
|
62 | (13) |
|
Characteristics of an Entrepreneur |
|
|
63 | (1) |
|
Twenty Questions to Determine How Entrepreneurial You Are |
|
|
64 | (1) |
|
From Idea to Concept Evaluation |
|
|
65 | (3) |
|
Assessing Opportunity and Writing a Business Plan |
|
|
68 | (3) |
|
|
|
71 | (1) |
|
|
|
72 | (2) |
|
|
|
74 | (1) |
|
|
|
75 | (1) |
|
Study Plan and Assignments |
|
|
75 | (4) |
|
|
|
75 | (1) |
|
|
|
76 | (1) |
|
|
|
76 | (1) |
|
|
|
76 | (1) |
|
|
|
77 | (1) |
|
|
|
77 | (1) |
|
|
|
77 | (1) |
|
|
|
77 | (1) |
|
|
|
78 | (1) |
|
Introduction to US Patent Law |
|
|
79 | (38) |
|
|
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
Predicted Learning Outcomes |
|
|
80 | (1) |
|
|
|
81 | (32) |
|
Brief Description of US Patents |
|
|
81 | (2) |
|
Patentable Subject Matter |
|
|
83 | (1) |
|
|
|
84 | (1) |
|
|
|
85 | (3) |
|
|
|
88 | (2) |
|
|
|
90 | (1) |
|
|
|
91 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (4) |
|
Invention and Inventorship |
|
|
96 | (3) |
|
The Patent Process: Obtaining and Maintaining a Patent |
|
|
99 | (7) |
|
|
|
106 | (4) |
|
Patent Ownership and Intellectual Property Agreements |
|
|
110 | (3) |
|
|
|
113 | (1) |
|
Study Plan and Assignments |
|
|
113 | (4) |
|
|
|
113 | (1) |
|
|
|
113 | (1) |
|
|
|
113 | (1) |
|
|
|
114 | (1) |
|
|
|
114 | (1) |
|
|
|
114 | (1) |
|
|
|
114 | (1) |
|
|
|
115 | (1) |
|
|
|
115 | (2) |
|
Intellectual Property Management |
|
|
117 | (24) |
|
|
|
|
|
118 | (1) |
|
|
|
118 | (1) |
|
Predicted Learning Outcomes |
|
|
119 | (1) |
|
|
|
119 | (16) |
|
|
|
120 | (1) |
|
Globalization of Innovation |
|
|
121 | (1) |
|
|
|
122 | (1) |
|
|
|
123 | (1) |
|
|
|
124 | (1) |
|
|
|
124 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
Probability of Technological Success (Technology Risk) |
|
|
126 | (1) |
|
|
|
126 | (1) |
|
Mapping the Competitive Patent Landscape |
|
|
127 | (1) |
|
|
|
128 | (1) |
|
Indentification of Relevant Patent Documents |
|
|
129 | (1) |
|
Mapping of Relevant Patent Documents |
|
|
129 | (3) |
|
Screening Out Clearly Noninfringing Patents |
|
|
132 | (1) |
|
Analyzing Potentially Infringing Patents |
|
|
132 | (2) |
|
Analyzing Clearly Infringing Patents |
|
|
134 | (1) |
|
|
|
135 | (1) |
|
|
|
135 | (1) |
|
Study Plan and Assignments |
|
|
135 | (6) |
|
|
|
135 | (1) |
|
|
|
136 | (1) |
|
|
|
137 | (1) |
|
|
|
138 | (1) |
|
|
|
139 | (1) |
|
|
|
140 | (1) |
|
|
|
140 | (1) |
|
|
|
140 | (1) |
|
Operational Excellence in Pharmaceutical Manufacturing |
|
|
141 | (34) |
|
|
|
|
|
143 | (1) |
|
|
|
143 | (1) |
|
|
|
143 | (2) |
|
Overview of the Drug Manufacturing Process |
|
|
143 | (1) |
|
A Change in Paradigm for the Pharmaceutical Industry |
|
|
144 | (1) |
|
Part I --- Operational Excellence: Implementing Process Improvements |
|
|
145 | (3) |
|
Introduction to Lean Manufacturing |
|
|
145 | (3) |
|
Predicted Learning Outcomes |
|
|
148 | (1) |
|
|
|
149 | (1) |
|
|
|
149 | (1) |
|
Study Plan and Assignments |
|
|
150 | (7) |
|
|
|
150 | (1) |
|
|
|
151 | (2) |
|
|
|
153 | (1) |
|
|
|
154 | (1) |
|
|
|
154 | (2) |
|
|
|
156 | (1) |
|
|
|
156 | (1) |
|
|
|
157 | (1) |
|
Company Supervised Practicum |
|
|
157 | (4) |
|
Part II - Optimizing Existing Technologies |
|
|
161 | (1) |
|
Introduction to Quality Control |
|
|
161 | (1) |
|
Predicted Learning Outcomes |
|
|
161 | (1) |
|
|
|
162 | (1) |
|
|
|
163 | (1) |
|
Study Plan and Assignments |
|
|
163 | (6) |
|
|
|
163 | (1) |
|
|
|
164 | (1) |
|
|
|
165 | (1) |
|
|
|
166 | |
|
|
|
5 | (163) |
|
|
|
168 | (1) |
|
|
|
168 | (1) |
|
|
|
168 | (1) |
|
Company Supervised Practicum |
|
|
169 | (4) |
|
|
|
173 | (2) |
|
Aligning Behaviors and Standards in a Regulated Industry: Design and Implementation of a Job Observation Program |
|
|
175 | (9) |
|
|
|
|
|
|
|
176 | (1) |
|
|
|
176 | (1) |
|
Predicted Learning Outcome |
|
|
177 | (1) |
|
|
|
177 | (2) |
|
Human Error and Human Error Prevention by Job Observation |
|
|
177 | (1) |
|
Procedural Adherence and Human Behavior |
|
|
178 | (1) |
|
The Necessity for Job Observation |
|
|
178 | (1) |
|
|
|
179 | (2) |
|
|
|
181 | (1) |
|
Study Plan and Assignments |
|
|
181 | (2) |
|
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
183 | (1) |
|
|
|
183 | (1) |
|
Items Needed for a Widely Applicable Job Observation Program |
|
|
183 | (1) |
|
Job Observation Program Evaluation |
|
|
184 | (1) |
|
Appendix A: Job Observation Program for a Commercial Kitchen |
|
|
184 | (6) |
|
|
|
185 | (1) |
|
|
|
185 | (1) |
|
Example Form: Job Observation --- Commercial Cooking |
|
|
186 | (1) |
|
Items for the basis of an observation program |
|
|
187 | (3) |
|
Appendix B: Job Observation Program for GMP Documentation in a Manufacturing Facility |
|
|
190 | (5) |
|
|
|
190 | (1) |
|
|
|
190 | (1) |
|
Example Form: Job Observation for GMP Documentation in a Manufacturing Facility |
|
|
191 | (1) |
|
Comparison: Manufacturing Observation Program vs. Standards |
|
|
191 | (1) |
|
Items for the basis of an observation program |
|
|
191 | (4) |
|
|
|
195 | (2) |
|
|
|
195 | (1) |
|
|
|
196 | (1) |
| Subject Index |
|
197 | |